Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Sep 1;156(3):731-43.
doi: 10.1084/jem.156.3.731.

Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure

Serologic identification of the human secondary B cell antigens. Correlations between function, genetics, and structure

S Shaw et al. J Exp Med. .

Abstract

The secondary B cell (SB) antigens are polymorphic HLA-linked antigens on human B cells and macrophages that are identified by primed T cell responses but are genetically distinct from the HLA-DR, MB, and MT antigens. Serologic identification of the SB molecule, using the monoclonal antibody ILR1, now makes it possible to correlate the function of these determinants in human T cell recognition with an Ia-like molecular structure and a genetic locus that marks a new HLA subregion. Three lines of evidence indicate that the ILR1 molecule identifies an epitope on some alleles of the SB gene: (a) the polymorphism of ILR1 -reactivity in the population correlates with SB2 SB3; (b) T cell proliferative response to SB2 and SB3 are specifically inhibited by ILR1; and (c) ILR1 reactivity is exactly concordant with the expression of SB2 in a panel of HLA-deletion mutant lymphoblastoid cell line. Together with previous studies, these results indicate that the SB antigens are on Ia-like molecules. Furthermore, the serologic studies of HLA-deletion mutant cell lines demonstrate that there are two HLA regions centromeric to HLA-B controlling expression of Ia-like molecules: a region toward HLA-B that controls expression of HLA-DR, and a region toward GLO that controls expression of SB.

PubMed Disclaimer

References

    1. J Exp Med. 1978 Dec 1;148(6):1592-611 - PubMed
    1. Nature. 1979 Feb 8;277(5696):478-80 - PubMed
    1. J Exp Med. 1979 Aug 1;150(2):246-55 - PubMed
    1. Science. 1979 Oct 19;206(4416):292-7 - PubMed
    1. J Exp Med. 1979 Dec 1;150(6):1472-82 - PubMed

Publication types